Newsletter 37/2025

/in /by

LAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi fellow warriors! This week too, despite my commitments, I found something interesting for you. Science is moving fast! Stay strong and fight on! As usual, we also have a podcast if you prefer to listen to the newsletter, you can find it […]

Read more

Newsletter 36/2025

/in /by

LAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi fellow warriors! This week we have “only” four news items, but they are very good, especially the update on the ARCHES trial. Stay strong and fight on! As usual, we also have a podcast if you prefer to listen to the […]

Read more

Another Trial Supports Low-Dose Abiraterone Acetate in mCRPC

/in , , /by

This study, published in JCO Global Oncology and focused on abiraterone acetate (AA), a drug used to treat metastatic castration-resistant prostate cancer, suggests that a smaller dose of AA is as effective as the standard dose (we already talked about another study pointing in the same direction in Singapore, but this sample is bigger). The […]

Read more